Phone:| Tech Support:| E-mail:
Image Product # Product Name Description Operation
  • DNA Ligase from T4-infected Escherichia coli
    TL0030

    Sorafenib Tosylate is the tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0081

    Trametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0082

    Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0103

    SCH772984 is a novel, specific inhibitor of ERK1/2 with IC50 values of 4 nM and 1 nM in cell-free assay, respectively, And show robust efficacy in RAS- or BRAF-mutant cancer cells.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0158

    SB203580 is a p38 MAPK inhibitor.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0285

    Vemurafenib is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
  • DNA Ligase from T4-infected Escherichia coli
    TL0492

    Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
    • TL0492-10MG
      In stock
      99
      - +
      TL0492-25MG
      In stock
      156.4
      - +
      TL0492-100MG
      In stock
      414
      - +
      TL0492-500MG
      In stock
      1138.6
      - +
  • DNA Ligase from T4-infected Escherichia coli
    TL0498

    Dabrafenib Mesylate is the mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.

    Price
    SKU-Pack Size
    Stock
    Price($)
    Quantity
1 2 3 4 5 Next End
天问科技